NCT06909851 Comparison of Pain Relief After Arthroscopic Knee Surgery: Adductor Canal Block and Genicular Nerve Block
| NCT ID | NCT06909851 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Başakşehir Çam & Sakura City Hospital |
| Condition | Opioid Use |
| Study Type | INTERVENTIONAL |
| Enrollment | 68 participants |
| Start Date | 2025-03-10 |
| Primary Completion | 2025-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 68 participants in total. It began in 2025-03-10 with a primary completion date of 2025-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective randomized study aims to compare the analgesic efficacy of Adductor Canal Block (ACB) and Genicular Nerve Block (GNB) groups to relieve postoperative pain in participants between ages of 18-72 undergoing arthroscopic knee surgery under spinal anesthesia. The main question it aims to answer is: To demonstrate whether Adductor Canal Block or Genicular Nerve Block is more effective in postoperative analgesia in patients undergoing arthroscopic knee surgery based on pain scores, opioid consumption and patient satisfaction. Arthroscopic knee surgeries cause severe pain especially with movement in the post-operative period. After surgery, the movements of the participants are severely restricted because of pain, which increases the possibility of complications and postpones post-operative knee exercises. In this study, the participants' pain status, VAS score, opioid consumption and patient satisfaction will be measured with a simple scoring system for 24 hours at predetermined time points and then compared. Both types of blocks have pain-relieving effects. This study will only investigate which one is more effective in reducing pain, and there will be no deficiency in relieving the pain of the participants.
Eligibility Criteria
Inclusion Criteria: * Voluntary willingness to participate in the study. * Patients undergoing arthroscopic knee surgery (meniscus, ACL, arthroscopic intervention etc). * ASA I-II-III classification. * Aged between 18-72 years. * No contraindications for regional anesthesia, and deemed suitable for regional anesthesia by the anesthesiologist. * Undergoing surgery under spinal anesthesia. * Fully oriented and able to cooperate. Exclusion Criteria: * Undergoing surgery under general anesthesia. * Chronic analgesic use. * Presence of an active infection at the procedure site. * Outside the appropriate age range. * Inability to comply with postoperative pain/NRS follow-ups. * ASA IV-V classification. * Non-voluntary patients. * Pregnancy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06909851 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 72 Years, studying Opioid Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06909851 currently recruiting?
Yes, NCT06909851 is actively recruiting participants. Contact the research team at dr.m.gencer07@gmail.com for enrollment information.
Where is the NCT06909851 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06909851 clinical trial?
NCT06909851 is sponsored by Başakşehir Çam & Sakura City Hospital. The trial plans to enroll 68 participants.